An investigational stent retriever device delivered successful revascularization in more than 85% of patients with primary distal vessel occlusion ischemic stroke at 24 hours, researchers reported at ...
NEW ORLEANS -- Loberamisal improved functional outcomes after acute ischemic stroke in a placebo-controlled phase III trial, raising its prospects as an investigational neuroprotective therapy. In ...
Hello. Good morning and good afternoon, everybody, and welcome to our investor webinar on the results of the OCEANIC-STROKE Phase III trial directly live from ISC 2026 in New Orleans. So my name is ...
Stroke patients with a cerebral vessel occlusion that is clearly visible on brain imaging are potential candidates for intra-arterial thrombolysis. Preliminary evidence indicates that the NIH Stroke ...
NEW ORLEANS -- A stronger case could be made for intra-arterial (IA) alteplase after successful mechanical thrombectomy based on more randomized data, this time the CHOICE-2 trial from Spain. In acute ...
New stroke breakthroughs spotlight faster treatment, factor XI prevention, better recovery, and the push to deliver care equitably with smart wearables. The future of stroke care is likely to be ...
NEW ORLEANS -- Factor XIa (FXIa) inhibition for secondary stroke prevention got a major win in the large OCEANIC-STROKE placebo-controlled trial. Among adults with acute non-cardioembolic ischemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results